AAAAAA

   
Results: 1-13 |
Results: 13
Economic decision analysis model of screening for lung cancer
Authors: Marshall, D Simpson, KN Earle, CC Chu, CW
Citation: D. Marshall et al., Economic decision analysis model of screening for lung cancer, EUR J CANC, 37(14), 2001, pp. 1759-1767
Effectiveness of chemotherapy for advanced lung cancer in the elderly: Instrumental variable and propensity analysis
Authors: Earle, CC Tsai, JS Gelber, RD Weinstein, MC Neumann, PJ Weeks, JC
Citation: Cc. Earle et al., Effectiveness of chemotherapy for advanced lung cancer in the elderly: Instrumental variable and propensity analysis, J CL ONCOL, 19(4), 2001, pp. 1064-1070
Potential cost-effectiveness of one-time screening for lung cancer (LC) ina high risk cohort
Authors: Marshall, D Simpson, KN Earle, CC Chu, CW
Citation: D. Marshall et al., Potential cost-effectiveness of one-time screening for lung cancer (LC) ina high risk cohort, LUNG CANC, 32(3), 2001, pp. 227-236
Oxaliplatin-induced Evan's syndrome
Authors: Earle, CC Chen, WY Ryan, DP Mayer, RJ
Citation: Cc. Earle et al., Oxaliplatin-induced Evan's syndrome, BR J CANC, 84(3), 2001, pp. 441-441
Outcomes research in oncology: History, conceptual framework, and trends in the literature
Authors: Lee, SJ Earle, CC Weeks, JC
Citation: Sj. Lee et al., Outcomes research in oncology: History, conceptual framework, and trends in the literature, J NAT CANC, 92(3), 2000, pp. 195-204
Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer
Authors: Berthelot, JM Will, BP Evans, WK Coyle, D Earle, CC Bordeleau, L
Citation: Jm. Berthelot et al., Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer, J NAT CANC, 92(16), 2000, pp. 1321-1329
Systematic overview of cost-utility assessments in oncology
Authors: Earle, CC Chapman, RH Baker, CS Bell, CM Stone, PW Sandberg, EA Neumann, PJ
Citation: Cc. Earle et al., Systematic overview of cost-utility assessments in oncology, J CL ONCOL, 18(18), 2000, pp. 3302-3317
An assessment of methods to combine published survival curves
Authors: Earle, CC Wells, GA
Citation: Cc. Earle et Ga. Wells, An assessment of methods to combine published survival curves, MED DECIS M, 20(1), 2000, pp. 104-111
Who gets chemotherapy for metastatic lung cancer?
Authors: Earle, CC Venditti, LN Neumann, PJ Gelber, RD Weinstein, MC Potosky, AL Weeks, JC
Citation: Cc. Earle et al., Who gets chemotherapy for metastatic lung cancer?, CHEST, 117(5), 2000, pp. 1239-1246
Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting a meta-analysis of randomised trials
Authors: Earle, CC Maroun, JA
Citation: Cc. Earle et Ja. Maroun, Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting a meta-analysis of randomised trials, EUR J CANC, 35(7), 1999, pp. 1059-1064
Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-celllung cancer
Authors: Earle, CC Evans, WK
Citation: Cc. Earle et Wk. Evans, Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-celllung cancer, BR J CANC, 80(5-6), 1999, pp. 815-820
Evidence-based medicine: A cup half full or half empty?
Authors: Earle, CC Weeks, JC
Citation: Cc. Earle et Jc. Weeks, Evidence-based medicine: A cup half full or half empty?, AM J MED, 106(2), 1999, pp. 263-264
A phase I study of gemcitabine/cisplatin/etoposide in the treatment of small-cell lung cancer
Authors: Earle, CC Stewart, DJ Cormier, Y Evans, WK Gertler, SZ Mihalcioiu, C Walde, PD
Citation: Cc. Earle et al., A phase I study of gemcitabine/cisplatin/etoposide in the treatment of small-cell lung cancer, LUNG CANC, 22(3), 1998, pp. 235-241
Risultati: 1-13 |